Remove Healthcare Remove Manufacturing Remove Pharmacology Remove Safety
article thumbnail

Achieving pharmaceutical drug traceability compliance

European Pharmaceutical Review

Key attributes of an enterprise resource planning (ERP) system required for drug traceability has been published in a Universal Journal of Pharmacy and Pharmacology paper. These included increased process complexity, changing consumer behaviour, healthcare reforms, a rise in the quantity of data without adequate infrastructure to utilise it.

article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

1,2 Moreover, except for countries such as Czechia, Denmark and Germany, the cost of these medications is borne by the patient, rather than national insurance or healthcare systems. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry. Mechoulam R.

Medical 84
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

However, health specialists refute most safety concerns for the use of drug classes as part of gender affirming care, citing years of research and care. With restricted access and reduced prescription of puberty blockers and hormone therapies, the impact on pharmaceutical companies manufacturing these therapies also remains unclear.

Ethics 144
article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

Expanding this approach to simultaneously build capabilities and clinical trials in developing and underserved regions, like APAC and less wealthy healthcare systems in Latin America and Europe, is essential to driving more comprehensive clinical programmes and health equity.